bleeding concerns about Avastin (bevacizumab)
August 2004
There are new bleeding concerns about Avastin (bevacizumab) used for metastatic colorectal cancer.
This specific topic you are searching for was not covered in the newsletter. As important new information is received, we want to provide our subscribers with it. As an extra service to our subscribers we are offering the Detail-Document.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote